MedTrace Logo

18F-MFBG Cardiac Imaging for Heart Failure Administration

NCT06149195 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-01-24

No results posted yet for this study

Summary

The clinical feasibility of 18F-FMBG cardiac PET imaging will be observed in sympathetic nervous system activity in patients with heart failure, predicted cardiac events, guided ICD implantation, and evaluated therapy efficiency.

Conditions

  • Rest Gated Myocardial Perfusion Imaging in Heart Failure

Interventions

DIAGNOSTIC_TEST

Standard medical care for heart failure

Standard treatment and care for heart failure patients from the heart failure center of Sichuan Provincial People's Hospital.

Sponsors & Collaborators

  • Sichuan Provincial People's Hospital

    lead OTHER

Principal Investigators

  • Zhi Ling Ding · China, Sichuan Departments of Nuclear Medicine, Sichuan Provincial People's Hospita

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2025-12-31
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06149195 on ClinicalTrials.gov